Request for feedback: Proposed generic concept for COVID-19 protein subunit vaccines

Hi everyone,

A generic concept has been proposed for COVID-19 protein subunit vaccines, which is the vaccine technology platform that is used by the COVID-19 Novavax vaccine product.

The proposed concept is as follows:
FSN: Vaccine product containing* only* Severe acute respiratory syndrome coronavirus 2 recombinant protein antigen
Semantic tag: medicinal product
PT: Canadian Preferred term could remain as proposed, COVID-19 protein subunit vaccine

The full rationale and supporting documentation for this proposed concept can be found on the RFC: informs.infoway-inforoute.ca/browse/SCT-11336?filter=-2

Please let the CVC team know if you have any feedback on this approach. We will also add this to the agenda for review and discussion at the next CVC monthly working group meeting.

Thank you,
Taylor